CBLL250516C30000
- 0.00
- 0.000.00%
Ceribell Newsroom
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm
Express News | FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
BofA Securities Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32
CCORF Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $33
William Blair Maintains Ceribell(CBLL.US) With Buy Rating
Top Midday Gainers
Sector Update: Health Care Stocks Gain in Afternoon Trading
Sector Update: Health Care
CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Does CeriBell (NASDAQ:CBLL) Have A Healthy Balance Sheet?
U.S. Tariffs Prompt Ceribell To Estimate Limited Near-Term Impact On Costs For China-Sourced Headbands, With Sufficient U.S. Inventory To Cover Demand Through Q3 2025 And No Material Financial Effect Expected Until Q4
Express News | Ceribell Inc - No Material Impact to Financial Results From Incremental Tariffs Until at Least the Fourth Quarter of 2025
Express News | Ceribell Inc - Expects 8-10 Percentage Point Impact on Gross Margins Due to Tariffs - SEC Filing
Express News | Ceribell Inc - Expects Sufficient Supply of Headband Product Through Q3 2025 - SEC Filing
With 49% Stake, CeriBell, Inc. (NASDAQ:CBLL) Seems to Have Captured Institutional Investors' Interest
12 Health Care Stocks Moving In Monday's Pre-Market Session
Ladenburg Thalmann Initiates Ceribell(CBLL.US) With Buy Rating, Announces Target Price $32
This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
CeriBell Initiated at Buy by Ladenburg Thalmann